Therapeutic Goods (Permissible Ingredients—Information that Must Accompany Application for Variation) Determination 2023 (Cth)

Therapeutic Goods (Permissible Ingredients—Information that Must Accompany Application for Variation) Determination 2023

I, Nicholas Henderson, as delegate of the Secretary of the Department of Health and Aged Care, make the following determination.

Dated 24 January 2023

Nicholas Henderson Acting First Assistant Secretary Medicines Regulation Division Health Products Regulation Group Department of Health and Aged Care

Contents 1 Name 2 Commencement 3 Authority 4 Definitions 5 Kind of information 6 Form of information

1 Name This instrument is the Therapeutic Goods (Permissible Ingredients—Information that Must Accompany Application for Variation) Determination 2023.

2 Commencement (1) Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

Commencement information Column 1 Column 2 Column 3 Provisions Commencement Date/Details 1. The whole of this instrument 1 February 2023. 1 February 2023

Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument. (2) Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

3 Authority This instrument is made under subsections 26BD(8) and (9) of the Therapeutic Goods Act 1989.

4 Definitions Note: A number of expressions used in this instrument are defined in subsection 3(1) of the Act, including the following: (a) Secretary. In this instrument: Act means the Therapeutic Goods Act 1989. Therapeutic Goods Administration means the part of the Department known as the Therapeutic Goods Administration.